Navigation Links
WuXi PharmaTech Announces Second Quarter 2011 Results
Date:8/10/2011

12288;Operating expenses:

 

 

 

 

 

 

 

 Selling and marketing expenses

 

(2,547)

(2,333)

9.2%

 

(4,505)

(4,615)

(2.4%)General and administrative expenses

 

(14,569)

(14,785)

(1.5%)

 

(27,466)

(25,485)

7.8%Total operating expenses(17,116)

(17,118)

(0.0%)

 

(31,971)

(30,100)

6.2%Operating income 

21,513

16,089

33.7%

 

41,353

33,525

23.3% 

 

 

 

 

 

 

 

 Other income (expenses),net

 

149

433

(65.6%)

 

1,776

616

188.3%Interest income (expenses), net

975

159

513.2%

 

1,806

257

602.7%Total other income (expenses), net 

1,124

592

89.9%

 

3,582

873

310.3% 

 

 

 

 

 

 

 

 Income before income taxes 

22,637

16,681

35.7%

 

44,935

34,398

30.6%Income tax expense

 

(3,986)

(2,923)

36.4%

 

(8,060)

(5,122)

57.4%Net income 

18,651

13,758

35.6%

 

36,875

29,276

26.0% 

 

 

 

 

 

 

 

 Basic net earnings per ADS 

0.26

0.20

32.8%

 

0.52


'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
2. WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
3. WuXi PharmaTech Announces First-Quarter 2011 Results
4. WuXi PharmaTech Files 2010 Annual Report on Form 20-F
5. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
6. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
7. WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release
8. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
9. WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
10. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
11. WuXi PharmaTech Announces Third-Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... Aug. 27, 2015 DURECT Corporation (Nasdaq: ... present at three upcoming healthcare conferences.  ... will present at the Rodman & Renshaw Investment Conference ... The conference is being held at the St. Regis ... A live audio webcast of the presentation will be ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
... Simulation Corporation (MSC) is proud to offer innovative, guideline-based ... through the Health Care Innovation Challenge, announced on November ... Services. Simulation provides a unique, risk-free environment ... in managing patients with diagnoses associated with high mortality ...
... International Corporation (NASDAQ: PRXL ), a leading ... been selected as one of two strategic partners by ... services worldwide. PAREXEL will work with UCB ... to increase productivity and cost effectiveness. The ...
Cached Medicine Technology:Medical Simulation Corporation Offers Innovative Training Solutions for Healthcare Organizations Applying to the Department of Health and Human Services' Health Care Innovation Challenge 2UCB and PAREXEL Sign Strategic Partnership Agreement 2UCB and PAREXEL Sign Strategic Partnership Agreement 3UCB and PAREXEL Sign Strategic Partnership Agreement 4
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President Chris Bustamante ... Vice President of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado ... its reach and impact through innovative technologies and strategies. , “I am very proud ...
(Date:8/29/2015)... ... 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of ... will present an educational program titled “Asbestos and Your Health.” , The two and ... open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day weekend, the last ... on September 22nd this year). For IT security personnel, it should also mark the ... prove far more costly than a simple headache. , Joe Caruso, founder and CEO-CTO ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
... Exhibiting people evidence of the harm unhealthy habits do can ... of studies on biomarkers indicators of health or disease ... people's behaviour. ,They learned that if you reveal ... smoking it does encourage people to quit for fear ...
... percent of people, usually in middle age. People with the ... It is not the type of arthritis common in the ... the immune system goes awry and attacks the joints, causing ... stiffness. It is also linked to an increased risk of ...
... of a catastrophic conditions in organ transplant patients, Doctor's ... develop hardened arteries, a condition// called arteriosclerosis, in the ... team from the Maryland's Women's Hospital, USA, found ... during a year-long study. Dr James Fang, who led ...
... Alzheimer's is a degenerative brain disease that usually ... events or familiar tasks. The disease eventually leads// ... judgment. Communication becomes more difficult as the disease ... finish thoughts or follow directions. Eventually, most people ...
... Research suggests that anxiety during pregnancy can increase a ... indicated that women who were very anxious// in the ... behavioural problems. ,Lead researcher Professor Vivette Glover, ... to women who had extreme anxiety, and were frequently ...
... to Dr. John Poll, curing a laborious birth defect that ... sliced apart all the bones of her face but didn't ... a promising alternative to grueling bone grafts: Poll attached a ... each day with a screwdriver, slowly pulling out the sunken ...
Cached Medicine News:Health News:Surgery-Rigged pulley helps patients 2
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
The TBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of total bilirubin in serum and plasma...
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
Medicine Products: